They found that co-administration of PT enhance the sensitivity of drug-resistance MCF cells to DOX and improved the anti-tumor effect of DOX in mice subcutaneously injected with DOX-resistant breast cancer tumor cells, effects that could be explained by the modulation of the expression and function of P-gp [70]. Here, PGP is linked to neoplasm.